Our team has the expertise and capability in place to work on alternate formulation processes that can be handed off to the manufacturing team for scale-up.  Since technology transfer and scale-up work can be performed under the same roof, Althea can be your timely and cost-effective solution for your drug development needs.

Protein Formulation Technology - Crystalomics®

Althea’s protein formulation technology platform, Crystalomics®, utilizes protein crystallization and complexation technology for the development of sustained release and high concentration formulations.  The technology has already been proven in clinical trials through Phase II with a crystalline suspension of recombinant human growth hormone, while manufacturability has also been demonstrated by the well-established, cGMP manufacturing process at Althea.